{"id":"https://openalex.org/W4411089977","doi":"https://doi.org/10.1016/j.jaip.2025.05.056","title":"Utility of IFN-\u03b3 Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell\u2013Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis Settings","display_name":"Utility of IFN-\u03b3 Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell\u2013Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis Settings","publication_year":2025,"publication_date":"2025-06-06","ids":{"openalex":"https://openalex.org/W4411089977","doi":"https://doi.org/10.1016/j.jaip.2025.05.056","pmid":"https://pubmed.ncbi.nlm.nih.gov/40484350","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12988537"},"language":"en","primary_location":{"id":"doi:10.1016/j.jaip.2025.05.056","doi":"https://doi.org/10.1016/j.jaip.2025.05.056","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jaip.2025.05.056","pdf_url":"https://www.jaci-inpractice.org/article/S2213-2198(25)00533-1/pdf","source":{"id":"https://openalex.org/S2754868259","display_name":"The Journal of Allergy and Clinical Immunology In Practice","issn_l":"2213-2198","issn":["2213-2198","2213-2201"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Allergy and Clinical Immunology: In Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.jaci-inpractice.org/article/S2213-2198(25)00533-1/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053875334","display_name":"Rose Selim","orcid":"https://orcid.org/0000-0001-6969-167X","observed_orcids":["https://orcid.org/0000-0001-6969-167X"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Rose Selim","raw_affiliation_strings":["Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007614414","display_name":"Bukiwe Nana Thwala","orcid":"https://orcid.org/0000-0002-3948-3121","observed_orcids":["https://orcid.org/0000-0002-3948-3121"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Bukiwe Thwala","raw_affiliation_strings":["Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053677354","display_name":"Mireille Porter","orcid":"https://orcid.org/0000-0002-4507-6995","observed_orcids":["https://orcid.org/0000-0002-4507-6995"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Mireille Porter","raw_affiliation_strings":["Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024335560","display_name":"Tafadzwa Chimbetete","orcid":"https://orcid.org/0000-0001-6972-4718","observed_orcids":["https://orcid.org/0000-0001-6972-4718"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Tafadzwa Chimbetete","raw_affiliation_strings":["Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117853078","display_name":"Precious Sethosa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Precious Sethosa","raw_affiliation_strings":["Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116207372","display_name":"Tebogo Malope","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Tebogo Malope","raw_affiliation_strings":["Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028219887","display_name":"Phuti Choshi","orcid":"https://orcid.org/0000-0001-8860-9635","observed_orcids":["https://orcid.org/0000-0001-8860-9635"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Phuti Choshi","raw_affiliation_strings":["Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057215968","display_name":"Sarah Pedretti","orcid":"https://orcid.org/0000-0003-4005-8453","observed_orcids":["https://orcid.org/0000-0003-4005-8453"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Sarah Pedretti","raw_affiliation_strings":["Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074254320","display_name":"Sipho Kenneth Dlamini","orcid":"https://orcid.org/0000-0003-0582-5987","observed_orcids":["https://orcid.org/0000-0003-0582-5987"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Sipho Dlamini","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Combined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Combined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080985934","display_name":"Elizabeth Jane Phillips","orcid":"https://orcid.org/0000-0002-7623-3383","observed_orcids":["https://orcid.org/0000-0002-7623-3383"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Jane Phillips","raw_affiliation_strings":["Center for Drug Safety and Immunology, Department of Medicine, Vanderbilt Medical Centre, Nashville, Tenn; Institute for Immunology and Infectious Diseases, Murdoch, Western Australia, Australia","Center for Drug Safety and Immunology, Department of Medicine, Vanderbilt Medical Centre, Nashville, Tennessee, United States; Institute for Immunology and Infectious Diseases, Murdoch, Western Australia, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Drug Safety and Immunology, Department of Medicine, Vanderbilt Medical Centre, Nashville, Tenn; Institute for Immunology and Infectious Diseases, Murdoch, Western Australia, Australia","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Center for Drug Safety and Immunology, Department of Medicine, Vanderbilt Medical Centre, Nashville, Tennessee, United States; Institute for Immunology and Infectious Diseases, Murdoch, Western Australia, Australia","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031509709","display_name":"Rannakoe J. Lehloenya","orcid":"https://orcid.org/0000-0002-1281-1789","observed_orcids":["https://orcid.org/0000-0002-1281-1789"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Rannakoe Lehloenya","raw_affiliation_strings":["Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Combined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Combined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009308092","display_name":"Jonny Peter","orcid":"https://orcid.org/0000-0002-2658-0723","observed_orcids":["https://orcid.org/0000-0002-2658-0723"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I2802258008","display_name":"Groote Schuur Hospital","ror":"https://ror.org/00c879s84","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I1307091933","https://openalex.org/I2802258008"]}],"countries":["ZA"],"is_corresponding":true,"raw_author_name":"Jonny Peter","raw_affiliation_strings":["Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa; Combined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa. Electronic address: jonny.peter@uct.ac.za"],"raw_orcid":"https://orcid.org/0000-0002-2658-0723","affiliations":[{"raw_affiliation_string":"Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa; Combined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa. Electronic address: jonny.peter@uct.ac.za","institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5009308092"],"corresponding_institution_ids":["https://openalex.org/I157614274","https://openalex.org/I2802258008"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":{"value":4000,"currency":"USD","value_usd":4000},"fwci":2.8062,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.90635463,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"13","issue":"12","first_page":"3336","last_page":"3343"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trimethoprim-sulfamethoxazole","display_name":"trimethoprim-sulfamethoxazole","score":0.902999997138977},{"id":"https://openalex.org/keywords/severe-cutaneous-adverse-reactions","display_name":"severe cutaneous adverse reactions","score":0.9409999847412109},{"id":"https://openalex.org/keywords/ifn-gamma-elispot","display_name":"IFN-gamma ELISPOT","score":0.8870000243186951},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.5519999861717224},{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.8859999775886536},{"id":"https://openalex.org/keywords/drug-causality-assessment","display_name":"drug causality assessment","score":0.781000018119812},{"id":"https://openalex.org/keywords/sulfamethoxazole","display_name":"sulfamethoxazole","score":0.8140000104904175},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.7879999876022339},{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9400206804275513},{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.8071994185447693},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5334128737449646},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5314770340919495},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4318724274635315},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.16101622581481934},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0868324339389801}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015662","descriptor_name":"Trimethoprim, Sulfamethoxazole Drug Combination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D058501","descriptor_name":"Enzyme-Linked Immunospot Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jaip.2025.05.056","doi":"https://doi.org/10.1016/j.jaip.2025.05.056","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jaip.2025.05.056","pdf_url":"https://www.jaci-inpractice.org/article/S2213-2198(25)00533-1/pdf","source":{"id":"https://openalex.org/S2754868259","display_name":"The Journal of Allergy and Clinical Immunology In Practice","issn_l":"2213-2198","issn":["2213-2198","2213-2201"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Allergy and Clinical Immunology: In Practice","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12988537","doi":null,"is_oa":true,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40484350/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12988537/pdf/nihms-2148237.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Allergy Clin Immunol Pract","raw_type":"Text"},{"id":"pmid:40484350","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40484350","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of allergy and clinical immunology. In practice","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jaip.2025.05.056","doi":"https://doi.org/10.1016/j.jaip.2025.05.056","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jaip.2025.05.056","pdf_url":"https://www.jaci-inpractice.org/article/S2213-2198(25)00533-1/pdf","source":{"id":"https://openalex.org/S2754868259","display_name":"The Journal of Allergy and Clinical Immunology In Practice","issn_l":"2213-2198","issn":["2213-2198","2213-2201"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Allergy and Clinical Immunology: In Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G2347075150","display_name":null,"funder_award_id":"EDCTP2","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G2987951818","display_name":null,"funder_award_id":"TMA2017SF-1981","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G3355698053","display_name":"Improving Prediction of Drug Action","funder_award_id":"P50GM115305","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G5568316868","display_name":"IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)","funder_award_id":"K43TW011178","funder_id":"https://openalex.org/F4320337356","funder_display_name":"Fogarty International Center"},{"id":"https://openalex.org/G5970016102","display_name":"Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors","funder_award_id":"R01HG010863","funder_id":"https://openalex.org/F4320337348","funder_display_name":"National Human Genome Research Institute"},{"id":"https://openalex.org/G6302896519","display_name":"IMmune-mediated Adverse drug Reactions In African TB HIV endemic settings","funder_award_id":"TMA2017SF-1981","funder_id":"https://openalex.org/F4320338462","funder_display_name":"European and Developing Countries Clinical Trials Partnership"},{"id":"https://openalex.org/G9000875372","display_name":"Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)","funder_award_id":"R01AI152183","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000908289","display_name":"NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis","funder_award_id":"U01AI154659","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337348","display_name":"National Human Genome Research Institute","ror":"https://ror.org/00baak391"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"},{"id":"https://openalex.org/F4320338462","display_name":"European and Developing Countries Clinical Trials Partnership","ror":"https://ror.org/031jv9v19"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411089977.pdf","grobid_xml":"https://content.openalex.org/works/W4411089977.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1542823104","https://openalex.org/W1707333408","https://openalex.org/W2003788939","https://openalex.org/W2005561958","https://openalex.org/W2005673189","https://openalex.org/W2037262556","https://openalex.org/W2037985084","https://openalex.org/W2041776821","https://openalex.org/W2045391651","https://openalex.org/W2051267089","https://openalex.org/W2051646345","https://openalex.org/W2058730638","https://openalex.org/W2067978628","https://openalex.org/W2075543293","https://openalex.org/W2080789152","https://openalex.org/W2107621875","https://openalex.org/W2115832251","https://openalex.org/W2119260702","https://openalex.org/W2126346033","https://openalex.org/W2134537227","https://openalex.org/W2137458402","https://openalex.org/W2146090786","https://openalex.org/W2164740372","https://openalex.org/W2169327920","https://openalex.org/W2309945944","https://openalex.org/W2330661037","https://openalex.org/W2338746674","https://openalex.org/W2467312903","https://openalex.org/W2501319927","https://openalex.org/W2529814759","https://openalex.org/W2530890630","https://openalex.org/W2743330869","https://openalex.org/W2766535528","https://openalex.org/W2793184462","https://openalex.org/W2888276484","https://openalex.org/W2905191675","https://openalex.org/W2947999042","https://openalex.org/W2979520022","https://openalex.org/W3092581372","https://openalex.org/W3120548603","https://openalex.org/W3120814801","https://openalex.org/W4200444449","https://openalex.org/W4281650680","https://openalex.org/W4296741107","https://openalex.org/W4387357498","https://openalex.org/W4392355708","https://openalex.org/W4395083275","https://openalex.org/W4395455414","https://openalex.org/W4399427728","https://openalex.org/W4402283742","https://openalex.org/W4405141831"],"related_works":["https://openalex.org/W4281650680","https://openalex.org/W2005668317","https://openalex.org/W3007649907","https://openalex.org/W2793444288","https://openalex.org/W6979747386","https://openalex.org/W3203638846","https://openalex.org/W4306711412","https://openalex.org/W4415493930","https://openalex.org/W4410838765","https://openalex.org/W4394757821"],"abstract_inverted_index":{"BACKGROUND:":[0],"Cotrimoxazole":[1,118,274],"is":[2,20,303],"a":[3,264],"broad-spectrum":[4],"antibiotic":[5],"associated":[6],"with":[7,17,25,70,130,168,202,209,227],"severe":[8],"cutaneous":[9],"adverse":[10],"drug":[11,33,52,128,147,152,225],"reactions":[12,129,226],"(SCARs).":[13],"In":[14],"persons":[15,166],"living":[16,167],"HIV,":[18],"cotrimoxazole":[19,48,88,109,301],"typically":[21],"used":[22],"in":[23,46,53,123,218,293,296],"combination":[24],"other":[26],"SCAR-associated":[27],"medications,":[28],"creating":[29],"challenges":[30],"for":[31,77,238,300],"culprit":[32,51,122],"ascertainment.":[34],"OBJECTIVE:":[35],"To":[36],"investigate":[37],"the":[38,50,65,120],"utility":[39],"of":[40,57,74,108,137,178,186,200,207,266,269,292],"IFN-\u03b3":[41,91,180,203,213,247,275],"release":[42],"enzyme-linked":[43],"immunospot":[44],"(ELISpot)":[45],"identifying":[47],"as":[49],"SCAR.":[54],"METHODS:":[55],"Registry":[56],"Severe":[58],"Cutaneous":[59],"Adverse":[60],"Reactions-validated":[61],"SCAR":[62,125,245,302],"cases":[63,126,136],"from":[64,244],"prospective":[66],"AFRISCAR":[67],"patient":[68],"registry":[69],"Naranjo":[71],"and/or":[72],"Algorithm":[73],"Drug":[75],"Causality":[76],"Epidermal":[78],"Necrolysis":[79],"causality":[80,153],"scores":[81],"completed":[82],"were":[83,165,183,195,252],"eligible.":[84],"Diagnostic":[85],"assessments":[86],"included":[87],"patch":[89,284],"testing,":[90,285],"ELISpot,":[92],"and":[93,114,132,142,163,205,224,229,233,250,257,295],"oral":[94,210],"challenge.":[95],"ELISpot":[96,204,214,248,276],"was":[97,119,157,216,236],"performed":[98],"on":[99,150],"cryopreserved":[100],"peripheral":[101],"blood":[102],"mononuclear":[103],"cells":[104],"using":[105,263],"validated":[106],"concentrations":[107],"(trimethoprim/sulfamethoxazole),":[110],"its":[111],"metabolite":[112],"4-nitroso-sulfamethoxazole,":[113],"sulfamethoxazole":[115],"(sulfamethoxazole).":[116],"RESULTS:":[117],"probable":[121],"79":[124],"(55":[127],"eosinophilia":[131,228],"systemic":[133,230],"symptoms,":[134],"10":[135],"Stevens-Johnson":[138,219],"syndrome/toxic":[139,220],"epidermal":[140,221],"necrolysis,":[141],"14":[143],"generalized":[144],"bullous":[145],"fixed":[146],"eruptions)":[148],"based":[149],"clinical":[151],"assessment.":[154],"Mean":[155],"age":[156],"39":[158],"years":[159],"(SD,":[160],"11":[161],"years),":[162],"90%":[164],"HIV":[169],"(median":[170],"CD4":[171],"count,":[172],"77;":[173],"interquartile":[174],"range,":[175],"25-142).":[176],"Eighteen":[177],"73":[179],"ELISpots":[181],"(25%)":[182,223],"positive,":[184],"nine":[185],"which":[187],"reacted":[188],"only":[189],"to":[190,283],"4-nitroso-sulfamethoxazole":[191],"(50%).":[192],"Patch":[193],"tests":[194],"all":[196],"negative,":[197],"including":[198],"three":[199],"13":[201,208],"four":[206],"challenge":[211],"positivity.":[212],"positivity":[215],"similar":[217],"necrolysis":[222],"symptoms":[231],"(26%),":[232],"no":[234],"test":[235],"positive":[237],"samples":[239],"older":[240],"than":[241],"90":[242],"days":[243],"onset.":[246],"sensitivity":[249,282],"specificity":[251],"38%":[253],"(95%":[254,259],"CI,":[255,260],"9-76)":[256],"100%":[258],"40-100),":[261],"respectively,":[262],"cutoff":[265],"spot-forming":[267],"units/million":[268],"50":[270],"or":[271],"greater.":[272],"CONCLUSIONS:":[273],"had":[277],"overall":[278],"low":[279],"but":[280],"superior":[281],"offering":[286],"good":[287],"rule-in":[288],"utility.":[289],"Ongoing":[290],"optimization":[291],"vivo":[294],"vitro":[297],"diagnostic":[298],"tools":[299],"still":[304],"required.":[305]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-06-07T00:00:00"}